Dovramilast
Dovramilast, also known by its research code CC-11050, is an investigational oral drug classified as a selective phosphodiesterase-4 (PDE4) inhibitor. It is being developed for its anti-inflammatory properties, particularly in conditions involving immune dysregulation and chronic inflammation. Reference standards of Dovramilast API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Dovramilast
[catalogue_number] => PA 04 3200000
[category_ids] => ,70,75,76,78,82,
[chemical_name] =>
[weight] => 472.56
[form] => C24H28N2O6S
[cas] => 340019-69-4
[pslug] => 340019-69-4-dovramilast-pa043200000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 04 3200000
Molecular Formula : C24H28N2O6S
Molecular Weight : 472.56
